Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis.
Does giving segmental muscle vibration alter the response to botulinum toxin injections in the treatment of spasticity in people with multiple sclerosis? A single-blind randomized controlled trial.
Progressive Injury in Chronic Multiple Sclerosis Lesions Is Gender-Specific: A DTI Study.
TDP6, a brain-derived neurotrophic factor-based trkB peptide mimetic, promotes oligodendrocyte myelination.
Oral laquinimod for multiple sclerosis: beyond the anti-inflammatory effect.
Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.
Relationship between urodynamic findings and sexual function in multiple sclerosis patients with lower urinary tract dysfunction.
Perfusion and Diffusion Abnormalities of Multiple Sclerosis Lesions and Relevance of Classified Lesions to Disease Status.
Ozanimod: a better or just another S1P receptor modulator?
Aquaporin-4 autoimmunity masquerading as a brainstem tumor.
Anthocyanins suppress the secretion of proinflammatory mediators and oxidative stress, and restore ion pump activities in demyelination.
Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: From structural insights to post-transcriptional regulatory roles.
Chronic cerebrospinal venous insufficiency is not more prevalent in patients with mild multiple sclerosis: a sonographer-blinded, case-control ultrasound study.
Intractable Vomiting Antecedent to Optic Neuritis: An Early Clinical Clue to Neuromyelitis Optica.
Multiple sclerosis: Blood-based biomarkers provide insight into progressive MS.
Contribution of symptom clusters to multiple sclerosis consequences.
Ongoing clinical trials of TYSABRI
Neuroimmune semaphorin 4A as a drug and drug target for asthma.
Neuroinflammatory changes negatively impact on LTP: A focus on IL-1β
MObility ImproVEment with spasticity in multiple sclerosis in Europe: the MOVE 1 EU study.
Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
Major depression and multiple sclerosis - a case report.
MerTK Is a Functional Regulator of Myelin Phagocytosis by Human Myeloid Cells.
Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: A pilot study.
Autophagy Is Required for Neutrophil-Mediated Inflammation.

Pages